Tuberculosis innovations mean little if they cannot save lives

Madhukar Pai, Jennifer Furin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The past decade has seen the emergence of new diagnostics and drugs for tuberculosis, a disease that kills over 1.8 million people each year. However, these new tools are yet to reach scale, and access remains a major challenge for patients in low and middle income countries. Urgent action is needed if we are committed to ending the TB epidemic. This means raising the level of ambition, embracing innovation, increasing financial investments, addressing implementation gaps, and ensuring that new technologies reach those who need them to survive. Otherwise, the promise of innovative technologies will never be realized.

Original languageEnglish
Article numbere25956
JournaleLife
Volume6
DOIs
Publication statusPublished - 02-05-2017

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Fingerprint Dive into the research topics of 'Tuberculosis innovations mean little if they cannot save lives'. Together they form a unique fingerprint.

  • Cite this